Here are three takeaways:
1. The increase in healthcare expenditure, rise in cancer, CVD, CHD, disability and heart diseases are driving the market.
2. Minimally invasive surgeries have gained popularity due to a shorter hospital stay and shorter recovery period. These surgeries also offer less blood loss and fewer complications.
3. GE Healthcare, Siemens, Stryker, Olympus, Medtronic, Abbott Diagnostics, Toshiba medical systems, Boston scientific, J&J, Aesculap and Intuitive surgical lead the market.
More articles on devices:
FDA approves Mobi-C disc labeling update; includes 5-year study data: 6 things to know
Exactech launches Acapella One Cervical Spacer System: 5 key points
Life Spine releases devices for expandable lateral interbody fusions: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
